Nichi-Iko Pharmaceutical Co Ltd represents a commitment to delivering high-quality pharmaceutical products and improving patient's lives. With a strong corporate philosophy focused on integrity, innovation, and patient-centeredness, Nichi-Iko aims to contribute to society by providing safe and effective medications. The company has a holistic approach towards healthcare, ensuring accessibility and affordability of their products. Nichi-Iko prioritizes customer satisfaction, continuous research and development, and collaborative partnerships to address the evolving medical needs of patients. Through their dedication to quality, Nichi-Iko Pharmaceutical Co Ltd strives to create a positive impact in the pharmaceutical industry and enhance the well-being of people worldwide.

Nichi-Iko Pharmaceutical Co Ltd is primarily present in Japan, where it is headquartered. As a prominent pharmaceutical company, Nichi-Iko focuses on the manufacturing and distribution of generic drugs. With its strong presence in the Japanese market, Nichi-Iko serves a significant role in providing affordable healthcare solutions to the local population. While its primary presence is in Japan, Nichi-Iko also has a global presence through strategic collaborations and partnerships to expand its reach and contribute to the global pharmaceutical industry.

Nichi-Iko Pharmaceutical Co Ltd, a leading company in the pharmaceutical industry, has achieved several significant milestones. Over the years, the company has successfully expanded its market presence and product portfolio. It has established itself as a key player in the generic pharmaceuticals sector, offering high-quality and affordable generic drugs to the global market. Nichi-Iko Pharmaceutical Co Ltd has also achieved noteworthy growth through strategic collaborations and acquisitions, enhancing its research capabilities and market reach. These achievements have catapulted the company's reputation and positioned it as an innovative and reliable provider of pharmaceutical solutions worldwide.

Nichi-Iko Pharmaceutical Co Ltd, established in 1965, is a leading Japanese pharmaceutical company specializing in generic drugs. With its headquarters in Toyama, Japan, Nichi-Iko has a rich history of over 55 years in the industry. The company focuses on research and development, production, and sales of high-quality, affordable medications. Nichi-Iko aims to contribute towards better healthcare by providing accessible treatment options to patients worldwide. Over the years, Nichi-Iko has expanded its global presence through strategic partnerships and acquisitions, strengthening its position as a trusted provider of generic pharmaceuticals. Today, the company continues to innovate and drive advancements in the pharmaceutical field, forging a path towards a healthier future.

The main competitors of Nichi-Iko Pharmaceutical Co Ltd in the market include Towa Pharmaceutical Co Ltd, Sawai Pharmaceutical Co Ltd, and Eisai Co Ltd. These companies are recognized players in the pharmaceutical industry and pose notable competition to Nichi-Iko Pharmaceutical Co Ltd. Their presence and product offerings contribute to a competitive landscape within the market.

Nichi-Iko Pharmaceutical Co Ltd is primarily active in the pharmaceutical industry.

The business model of Nichi-Iko Pharmaceutical Co Ltd focuses on the development, manufacturing, and sales of generic pharmaceutical products. As one of Japan's leading generic drug manufacturers, Nichi-Iko aims to provide affordable and high-quality medications to a wide range of patients. The company places great emphasis on research and development, ensuring the constant improvement and expansion of their product portfolio. Through strategic partnerships and acquisitions, Nichi-Iko continues to strengthen its position in the global pharmaceutical market, while maintaining a strong commitment to meeting the healthcare needs of individuals worldwide.

สัดส่วนราคาต่อกำไรของ Nichi-Iko Pharmaceutical Co คือ -0.02

KUV ของ Nichi-Iko Pharmaceutical Co คือ 0.01

AlleAktien คุณภาพสกอร์สำหรับ Nichi-Iko Pharmaceutical Co คือ 2/10.

คาดหวัง Nichi-Iko Pharmaceutical Co มียอดขายอยู่ที่ 201.8 ล้านล้าน JPY

กำไร คาดหวัง Nichi-Iko Pharmaceutical Co คือ -109.65 ล้านล้าน JPY

Nichi-Iko Pharmaceutical Co Ltd is a Japanese pharmaceutical company that focuses on the manufacturing and distribution of pharmaceutical products. The company's business model is oriented towards the development, production, and marketing of generics. These medications are copies of well-known original preparations and are typically offered at a lower price. In recent years, the company has become one of the largest generic manufacturers in Japan through several acquisitions and collaborations. It also operates in the international market, including in the USA, Europe, Australia, and China. Nichi-Iko employs over 6,000 employees and operates in four main business areas: generics, biosimilars, innovative drugs, and contract manufacturing. Each of these areas has its own objectives and strategies to drive the company's growth. Generics The core business area of Nichi-Iko is the production of generics. The company offers a wide range of generic drugs used in various therapy areas such as cardiovascular diseases, gastroenterology, oncology, neurology, infectious diseases, and diabetes. Biosimilars Another important business area of Nichi-Iko is the manufacturing of biosimilars. These medications are biologics that have a similar structure and effect as originals. Nichi-Iko specializes in the development and production of biosimilars and offers them as a cost-effective alternative to expensive original preparations. Innovative drugs In addition to generics and biosimilars, Nichi-Iko also conducts research and development of innovative drugs. The company is working on the development of novel therapies for rare diseases and chronic conditions. The company's hope is to gain a competitive advantage over competitors with these products. Contract manufacturing Nichi-Iko also offers contract manufacturing (CMO) services. This includes the production of drugs for other pharmaceutical companies that do not have the capacity or technologies to manufacture them themselves. This business area has become an important driver of growth for the company. Products In addition to generics and biosimilars, Nichi-Iko offers a wide range of medications that can be used to treat various diseases. These include, among others, blood pressure-lowering medications, digestive disorders, antibiotics, painkillers, and cancer medications. The company also specializes in the production of medications for endocrinology, including drugs for the treatment of diabetes, thyroid, and adrenal gland problems. Conclusion Overall, Nichi-Iko is an innovative pharmaceutical company that specializes in the development and production of generics. Through acquisitions and collaborations, the company has become a significant player in the pharmaceutical industry and provides its products in various markets worldwide. The research and development activities of Nichi-Iko make the future of the company promising.

Nichi-Iko Pharmaceutical Co จ่ายเงินปันผล 0 JPY ผ่าน ครั้งในหนภายในหนึ่งปี.

ปัจจุบันไม่สามารถคำนวณเงินปันผลสำหรับ Nichi-Iko Pharmaceutical Co หรือบริษัทไม่จ่ายเงินปันผล.

ISIN ของ Nichi-Iko Pharmaceutical Co คือ JP3687200000

WKN ของ Nichi-Iko Pharmaceutical Co คือ A0DQVE.

ตัวย่อของ Nichi-Iko Pharmaceutical Co คือ 4541.T

ภายในช่วง 12 เดือนที่ผ่านมา Nichi-Iko Pharmaceutical Co จ่ายเงินปันผลทั้งหมด 20 JPY นี้เทียบเท่ากับอัตราผลตอบแทนจากเงินปันผลประมาณ 57.14 % สำหรับ 12 เดือนข้างหน้า Nichi-Iko Pharmaceutical Co คาดว่าจะจ่ายเงินปันผลทั้งหมด -25.82 JPY

อัตราผลตอบแทนเงินปันผลของ Nichi-Iko Pharmaceutical Co ในปัจจุบันคือ 57.14 %

Nichi-Iko Pharmaceutical Co จ่ายเงินปันผลทุกไตรมาส การจ่ายเงินปันผลจะเกิดขึ้นในเดือน เมษายน, ตุลาคม, เมษายน, ตุลาคม

Nichi-Iko Pharmaceutical Co จ่ายเงินปันผลทุกปีในช่วง 0 ปีที่ผ่านมา.

คาดว่าในช่วง 12 เดือนข้างหน้าจะมีการจ่ายเงินปันผลทั้งหมด -25.82 JPY ซึ่งเทียบเท่ากับผลตอบแทนจากเงินปันผลร้อยละ -73.78 %

Nichi-Iko Pharmaceutical Co ถูกจัดให้อยู่ในภาคส่วน 'สุขภาพ'

เพื่อรับเงินปันผลล่าสุดของ Nichi-Iko Pharmaceutical Co ในวันที่ 1/12/2564 ที่มูลค่า 10 JPY คุณจะต้องถือหุ้นไว้ในพอร์ตก่อนวันที่เป็น Ex-Tag ในวันที่ 29/9/2564

การจ่ายเงินปันผลครั้งล่าสุดเกิดขึ้นเมื่อวันที่ 1/12/2564

ในปี 2023 บริษัท Nichi-Iko Pharmaceutical Co ได้จ่ายเงินปันผลเป็นจำนวน 0 JPY

เงินปันผลของ Nichi-Iko Pharmaceutical Co จะถูกจ่ายใน JPY